local_hospital

Alergologie SKOPKOVA s.r.o.

Address
Korunni 595/76, Marianske Hory, 709 00 Ostrava, Czechia

Alergologie SKOPKOVA s.r.o. - Allergology & Respiratory Research Center

Alergologie SKOPKOVA s.r.o. is a specialized clinical research facility dedicated to advancing the understanding and treatment of allergic and respiratory conditions. The center demonstrates particular expertise in conducting controlled clinical trials evaluating novel therapeutic interventions for both adult and pediatric populations suffering from respiratory and allergic diseases.

  • Asthma management and rescue medication optimization studies
  • Seasonal allergic rhinitis and rhinoconjunctivitis research
  • Allergen immunotherapy trials in pediatric populations

The research center has extensive experience in evaluating innovative treatment approaches, including combination inhaled therapies for asthma control and sublingual immunotherapy for grass pollen-induced allergies. With capabilities to conduct both short-term efficacy assessments and long-term sustained efficacy evaluations, the center plays a crucial role in developing evidence-based treatment options for patients with allergic respiratory conditions across different age groups.

Site Overview

assignment
2
connected trials
corporate_fare
2
sponsors
science
12
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
2
Total trials linked
Moderately Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
1
Sponsors (total)
2
Active sponsors
1

Sponsor Network

Top 1 by active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 634 other sites in Czechia

description
Trial volume
2
Outperforms 44% of sites
public
Therapeutic diversity
2areas
Outperforms 63% of sites
groups
Sponsor diversity
2sponsors
Outperforms 50% of sites

Therapeutic Area Benchmark — Czechia

Select a therapeutic area to compare against other sites in Czechia.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Czechia

Market Share

Country: Czechia

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Alergologie SKOPKOVA s.r.o.

lock Showing 1 of 2 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Efficacy and Safety Evaluation of PQ Grass 27600 SU in Pediatric Patients with Grass Pollen-Induced Seasonal Allergic Rhinitis/RhinoconjunctivitisAllergy Therapeutics (UK) LimitedPhase IIIRecruitingSep 2024

IMP list

lock Showing 1 of 12 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
12 Grass Pollen Mixture1Unknown2024-09-062024-09-06

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.